MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products

Similar documents
EUCAST recommended strains for internal quality control

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

European Committee on Antimicrobial Susceptibility Testing

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

AMR Industry Alliance Antibiotic Discharge Targets

European Committee on Antimicrobial Susceptibility Testing

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Product Catalogue 2017 Clinical and Industrial Microbiology

What s new in EUCAST methods?

Product Catalogue 2016 Clinical and Industrial Microbiology

2 New products for 2014

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

EUCAST-and CLSI potency NEO-SENSITABS

Performance Information. Vet use only

2015 Antibiotic Susceptibility Report

Antimicrobial Susceptibility Testing: Advanced Course

2016 Antibiotic Susceptibility Report

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

British Society for Antimicrobial Chemotherapy

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

January 2014 Vol. 34 No. 1

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

January 2014 Vol. 34 No. 1

British Society for Antimicrobial Chemotherapy

Antimicrobial Susceptibility Testing: The Basics

Intrinsic, implied and default resistance

- the details, where possible, of the antibiotic products these companies supply or have supplied.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

BSAC standardized disc susceptibility testing method (version 8)

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Antimicrobial susceptibility

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

ESCMID Online Lecture Library. by author

56 Clinical and Laboratory Standards Institute. All rights reserved.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Antimicrobial Susceptibility Patterns

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Main objectives of the EURL EQAS s

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Concise Antibiogram Toolkit Background

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Measuring Antibiotic Use in NHSN

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

CONTAGIOUS COMMENTS Department of Epidemiology

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

REVOLUTIONARY. MMinimum. BBiofilm EEradication Concentration. inimizing WE HAVE FOUND THE ANSWER.

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

EARS Net Report, Quarter

Liofilchem. ID-AST systems

CONTAGIOUS COMMENTS Department of Epidemiology

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Antibacterial Resistance In Wales

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Recommendations to take it forward!

Version 8 January 2009

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Mongolia September 2012

EARS-Net Belgium Data call for 2016: Instructions for participating laboratories, including data definition. (version 4, 20/3/2017)

Antibacterial Resistance In Wales

* gender factor (male=1, female=0.85)

Quality assurance of antimicrobial susceptibility testing

ESCMID Online Lecture Library. by author

Available online at ISSN No:

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Should we test Clostridium difficile for antimicrobial resistance? by author

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Policy # MI_AST Department of Microbiology. Page Quality Manual

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

Transcription:

IVD solutions through partnership MASTDISCS AST Leading the field with a complete solution for AST and Identification disc testing Comprehensive range Premium quality products Compatible with EUCAST and CLSI standards Bespoke service available

MAST has been a manufacturer of antibiotic susceptibility test products since 1957, and continues to be at the forefront of developments in this field. With an ever-expanding portfolio of antibiotic susceptibility, combination and identification discs, MAST supplies the most comprehensive range available worldwide. MAST also offers a range of services including mastpharma development and mastpharma stability for the evaluation of novel antimicrobial compounds for the pharmaceutical industry. Disc diffusion is still the most popular method for determining bacterial antibiotic susceptibility in the treatment of infectious disease, as highlighted by the variety of international standardised procedures including The European Committee on Antimicrobial Susceptibility Testing (EUCAST), The Clinical and Laboratory Standards Institute (CLSI) and The British Society for Antimicrobial Chemotherapy (BSAC). From January 2016 BSAC guidelines were superseded by EUCAST. MAST continues to support laboratories with the supply of BSAC concentrations until January 2019. MASTDISCS are available as an extensive range of test discs presented in dispensing cartridges or vials, with quality assurance guaranteed in accordance to standardised test protocols as issued by the above national and international organisations. Disc Diffusion Susceptibility Testing Order No Product Packsize MASTDISCS - ANTIBIOTIC SUSCEPTIBILITY DISCS IN CARTRIDGES AND VIALS in Cartridges (5 50 discs per pack) STOCKCART Stock Susceptibility Cartridge Discs of a single type 1 pack FUNGCART Stock Antifungal Cartridge Discs of a single type 1 pack SPECIALCART Cartridge Discs made to special order* Min 18 packs VOLCART Cartridge Discs made to special order* Min 98 packs MASTDISCS (100 discs per vial) STOCKDISC Stock Susceptibility Discs of a single type 1 vial FUNGDISC Stock Antifungal Discs of a single type 1 pack SPECIALDISC Discs made to special order* Min 22 packs VOLDISC Discs made to special order* Min 97 packs TOOL/C *Set up charge for Special Discs in vials or cartridges per new A one off charge for customisation of each new specification specification 2 www.mastgrp.com

ANTIBIOTIC SUSCEPTIBILITY DISCS IN CARTRIDGES - STOCK RANGE Cartridges (unless otherwise stated) BSAC EUCAST CLSI 5 50 discs Amikacin 30 3 3 3 AK 30C Amoxicillin 2 3 - - A 2C Amoxicillin 10 3 - - A 10C Amoxicillin 25 3 - - A 25C Ampicillin 2 3 3 - AP 2C Ampicillin 10 3 3 3 AP 10C Ampicillin 25 3 - - AP 25C Ampicillin/Sulbactam 10-10 - - 3 SAM 20C Amoxicillin/clavulanic acid 2-1 3 3 - AUG 3C Amoxicillin/clavulanic acid 20-10 3 3 3 AUG 30C Azithromycin 15 3 3 3 ATH 15C Aztreonam 30 3 3 3 ATM 30C Bacitracin 10 units - - - BA 10C Cefaclor 30 3 3 3 CFC 30C Ceftibuten 30-3 3 CFB 30C Cefamandole 30 3-3 CMD 30C Cefadroxil 30 3 3 - CDX 30C Cefepime 30 3 3 3 CPM 30C Cefixime 5 3 3 3 CFM 5C Cefoperazone 30 3 - - CPZ 30C Cefotaxime 5 3 3 - CTX 5C Cefotaxime 30 3-3 CTX 30C Cefoxitin 10 3 - - FOX 10C Cefoxitin 30 3 3 3 FOX 30C Cefpodoxime 10 3 3 3 CPD 10C Ceftaroline 5-3 - CPT 5C Ceftaroline 30 - - 3 CPT 30C Ceftazidime/avibactam 10-4* - 3 - CZA 14C Ceftazidime/avibactam 30-20 - - 3 CZA 50C Ceftazidime 10-3 - CAZ 10C Ceftazidime 30 3 3 3 CAZ 30C Ceftriaxone 5 3-3 CRO 5C Ceftriaxone 30 3 3 3 CRO 30C Ceftolozane/tazobactam 30-10 - 3 3 C/T 40C Cefuroxime 5 3 - - CXM 5C Cefalexin 30 3 - - CFX 30C Cefradine 30 3 - - CRD 30C Cefuroxime 30 3 3 3 CXM 30C Cephalothin 30 3-3 KF 30C Cephazolin 30 - - 3 CZ 30C Chloramphenicol 10 3 - - C 10C Chloramphenicol 30 3 3 3 C 30C Ciprofloxacin 1 3 - - CIP 1C Ciprofloxacin 5 3 3 3 CIP 5C Clarithromycin 2 3 - - CLA 2C Clarithromycin 5 3 - - CLA 5C Clarithromycin 15-3 3 CLA 15C Clindamycin 2 3 3 3 CD 2C Doripenem 10-3 3 DOR 10C Doxycycline 30 3-3 DXT 30C Enrofloxacin 5 - - 3 ENF 5C Ertapenem 10 3 3 3 ETP 10C Erythromycin 5 3 - - E 5C Erythromycin 15-3 3 E 15C Florfenicol 30 - - - FFC 30C Fosfomycin 200/ Glucose-6-Phosphate 50 3-3 FOT 200C Fusidic Acid 10 3 3 - FC 10C Gentamicin 10 3 3 3 GM 10C www.mastgrp.com 3

ANTIBIOTIC SUSCEPTIBILITY DISCS IN CARTRIDGES - STOCK RANGE Cartridges (unless otherwise stated) BSAC EUCAST CLSI 5 50 discs Gentamicin 30-3 - GM 30C Gentamicin 120 - - 3 GM 120C Gentamicin 200 3 - - GM 200C Imipenem 10 3 3 3 IMI 10C Kanamycin 30 - - 3 K 30C Levofloxacin 1 3 - - LEV 1C Levofloxacin 5 3 3 3 LEV 5C Linezolid 10 3 3 - LZD 10C Linezolid 30 - - 3 LZD 30C Mecillinam 10 3 3 3 MEC 10C Meropenem 10 3 3 3 MEM 10C Metronidazole 2.5 - - - MZ 2.5C Metronidazole 5 3 - - MZ 5C Minocycline 30 3-3 MN 30C Moxifloxacin 1 3 - - MFX 1C Moxifloxacin 5 3 3 3 MFX 5C Mupirocin 5 3 - - MUP 5C Mupirocin 20 3 - - MUP 20C Mupirocin 200-3 - MUP 200C Nalidixic Acid 30 3 3 3 NA 30C Neomycin 10 3 - - NE 10C Neomycin 30 - - - NE 30C Netilmicin 10-3 - NET 10C Netilmicin 30 3 3 - NET 30C Nitrofurantoin 100-3 - NI 100C Nitrofurantoin 200 3 - - NI 200C Nitrofurantoin 300 - - 3 NI 300C Nitroxoline 30-3 - NIB30C Norfloxacin 2 3 - - NOR 2C Norfloxacin 10-3 3 NOR 10C Novobiocin 5 - - - NO 5C Ofloxacin 5 3 3 3 OFX 5C Oxacillin 1 3 3 3 OX 1C Pefloxacin 5-3 - PEF 5C Penicillin G 1 unit 3 3 - PG 1C Penicillin G 10 units - - 3 PG10C Piperacillin 30 - - - PRL 30C Piperacillin 75 3 - - PRL 75C Piperacillin 100 - - 3 PRL 100C Piperacillin/tazobactam 30-6 - 3 - PTZ 36C Piperacillin/tazobactam 75-10 3 - - PTZ 85C Piperacillin/tazobactam 100-10 - - 3 PTZ 110C Polymyxin B 300 units - - - PB 300C Quinupristin/dalfopristin 15 3-3 SYN 15C Rifampicin 2 3 - - RP 2C Rifampicin 5 3 3 3 RP 5C Spectinomycin 25 3 - - SPC 25C Streptomycin 10 3-3 S 10C Streptomycin 300-3 3 S 300C Teicoplanin 30 3-3 TEC 30C Temocillin 30 3 - - TEM 30C Tetracycline 10 3 - - T 10C Tetracycline 30-3 3 T 30C Ticarcillin 75 3-3 TC 75C Tigecycline 15 3 3 3 TGC 15C Ticarcillin/clavulanic acid 75-10 3-3 TIM 85C Tobramycin 10 3 3 3 TN 10C Trimethoprim 2.5 3 - - TM 2.5C 4 www.mastgrp.com

ANTIBIOTIC SUSCEPTIBILITY DISCS IN CARTRIDGES - STOCK RANGE Cartridges (unless otherwise stated) BSAC EUCAST CLSI 5 50 discs Trimethoprim 5 3 3 3 TM 5C Trimethoprim/sulfamethoxazole 1.25/23.75 3 3 3 TS 25C Vancomycin 5 3 3 - VA 5C Vancomycin 30 - - 3 VA 30C Blank discs - - - BD0680W/C SPECIALIST VETERINARY SUSCEPTIBILITY DISCS Description Order Code Cartridges Vials (unless otherwise stated) 5 50 discs 100 discs Cefquinome 30 CEQ30C/NCE - Gamithromycin 15 GAM15C/NCE - Marbofloxacin 5 MAR5C/NCE - Pradofloxacin 5 PRA5C/NCE - Tidlipirison 60 TIP60C/NCE - Tylosin 30 TY30C/NCE TY30/NCE ANTIBIOTIC SUSCEPTIBILITY DISCS IN VIALS - STOCK RANGE Vials (unless otherwise stated) BSAC EUCAST CLSI 100 discs Amikacin 30 3 3 3 AK30 Bacitracin 8 units - - - BA8 Bacitracin 10 units - - - BA10 Cefpodoxime 10 3 3 3 CPD10 Chloramphenicol 10 3 - - C10 Chloramphenicol 30 3 3 3 C30 Gentamicin 10 3 3 3 GM10 Imipenem 10 3 3 3 IMI10 Meropenem 10 3 3 3 MEM 10 Metronidazole 2.5 - - - MZ 2.5 Metronidazole 5 3 - - MZ 5 Nalidixic Acid 30 3 3 3 NA 30 Novobiocin 5 - - - NO 5 Oxacillin 1 3 3 3 OX 1 Penicillin G 1 unit 3 3 - PG 1 Penicillin G 2 units - - - PG 2 Vancomycin 5 3 3 - VA 5 Blank discs - - - BD0638W SELECT RANGE OF ANTIBIOTIC SUCSCEPTIBILITY DISCS IN CARTRIDGES - STOCK RANGE Cartridges (unless otherwise stated) BSAC EUCAST CLSI 5 50 discs Carbenicillin 100-3 - PY100C Telithromycin 15-3 - TEL15C www.mastgrp.com 5

Order No Product Mechanism Packsize (tests) ANTIFUNGAL SUSCEPTIBILITY DISCS IN CARTRIDGES AND VIALS - STOCK RANGE Description Order Code Cartridges Vials (unless otherwise stated) 5 50 discs 100 discs Amphotericin B 20 AMB 20C - Clotrimazole 10 CTM 10C - Econazole 10 ECN 10C - Fluconazole 10 FCN 10C - Fluconazole 25 FCN 25C FCN 25 Flucytosine 1 FY 1C - Ketoconazole 10 KCA 10C - Miconazole 10 MCL 10C - Nystatin 100 NY 100C - MASTDISCS Combi COMBINATION DISC SETS FOR THE DETECTION OF ANTIBIOTIC RESISTANCE D52C Extended Spectrum ß Lactamase Set ESßL 50 tests D62C Cefotaxime 30 & Cefotaxime 30/Clavulanic Acid 10 ESßL 150 tests D63C Cefepime 30 & Cefepime 30/Clavulanic Acid 10 ESßL 150 tests D64C Ceftazidime 30 & Ceftazidime 30/Clavulanic Acid 10 ESßL 150 tests D66C Cefpodoxime 10 & Cefpodoxime 10/Clavulanic Acid 1 ESßL 150 tests D67C Extended Spectrum ß Lactamase Set (CPD10) ESßL 50 tests D68C AmpC & ESBL Detection Set AmpC/ESßL 50 tests D69C AmpC Detection Set AmpC 50 tests D72C AmpC, ESBL & Carbapenemase Detection Kit AmpC/ESßL/Carbapenemases 50 tests D73C MAST Carba plus MBL/KPC/OXA 50 tests Additional carbapenemase screening and identification tests D74 MAST ICT A screening test for the detection of carbapenemase 25 tests production in Enterobacteriaceae, Pseudomonas and Acinetobacter spp. D71C MAST CAT-ID - For presumptive identification of Carbapenemase production 250 tests TEM30C To aid presumptive identification of OXA-48 5 x 50 discs 6 www.mastgrp.com

Order No Product Mechanism Packsize (tests) LOW STRENGTH PENICILLIN DISCS For detecting the emergence of penicillin resistance. (vials of 100 discs or 5 50 discs in cartridges) PG1 Penicillin G (vials) 1 unit 1 vial PG1C Penicillin G (cartridges) 1 unit 1 pack The following discs are available to special order and subject to 6 weeks lead time. PG0.03 Penicillin G (vials) 0.03 unit Min order 22 vials HIGH STRENGTH AMINOGLYCOSIDE DISCS The following discs are available to special order and subject to 6 weeks lead time. For detecting high level aminoglycoside resistance. (vials of 100 discs or 5 50 discs in cartridges) GM500C Gentamicin (cartridges) 500µg Min order K1000C Kanamycin (cartridges) 1000µg 18 packs K1000 Kanamycin (vials) 1000µg Min order 22 vials www.mastgrp.com 7

Order No Product Packsize DISCMASTER DISPENSER Robust and reliable antimicrobial cartridge disc dispensers designed for use with MASTDISCS Antimicrobial Susceptibility Test Cartridges. DISCMASTER Dispenser - 6 place (contact MAST for the product code of the latest model) 1 SILICA63 Silica Gel Capsule for DISCMASTER 6 place Dispenser 4 CANISTER Canister for DISCMASTER 6 place Dispenser 1 MDD16 DISCMASTER 16 Dispenser - 16 place 1 SILICA16 Silica Gel Capsule for DISCMASTER 16 Dispenser (MDD16) 2 v 4.0 CEA 0118 United Kingdom Mast Group Ltd. Mast House Derby Road, Bootle Merseyside L20 1EA Tel: + 44 (0) 151 933 7277 Fax: + 44 (0) 151 944 1332 e-mail: sales@mastgrp.com Germany Mast Diagnostica GmbH Feldstrasse 20 DE-23858 Reinfeld Tel: + 49 (0) 4533 2007 0 Fax: + 49 (0) 4533 2007 68 e-mail: mast@mast-diagnostica.de France Mast Diagnostic 12 Rue Jean-Jacques Mention CS 91106 80011 Amiens CEDEX 1 Tél. + 33 (0) 322 80 80 67 Fax + 33 (0) 322 80 99 22 e-mail: info@mast-diagnostic.fr www.mastgrp.com